Email address
[email protected]Contact number
(601) 985-4427Share profile
Band 6
Provided by Alyson Bustamante Jones
Pharmaceutical, Medical Device and Healthcare; Drug and Device Litigation; Tort, Transportation and Specialized Litigation; Groundwater and Chemical Exposure Litigation; Mass Torts
Alyson Jones serves as Practice Group Leader of Butler Snow’s Pharmaceutical, Medical Device and Healthcare Group. She represents pharmaceutical and medical device companies nationwide in complex product liability litigation, handling both large-scale coordinated matters and individual high-exposure cases. She is known for delivering strategic, business-focused defense solutions that align with her clients’ broader objectives.
Alyson regularly leads national and local teams of attorneys and advisors, managing all phases of litigation from early case assessment through dispositive motions and trial. Her experience spans coordinated proceedings, individual plaintiff litigation, and high-stakes matters in jurisdictions across the country. She is particularly valued for her ability to streamline case management, develop cohesive defense strategies, and efficiently oversee multi-jurisdictional litigation.
Her recent experience includes serving as lead counsel in securing summary judgment for a medical device manufacturer in the Middle District of Florida, as well as leadership roles in significant pharmaceutical and medical device matters pending in federal and state courts. She has also served in key coordination roles in large-scale litigation, including as liaison counsel and in leadership positions involving consolidated proceedings.
In addition to her case management experience, Alyson has served on multiple trial teams, including Jackson v. McNeil Consumer Healthcare, recognized as one of CVN’s Top 2015 Defense Verdicts. She also frequently serves as discovery counsel in complex pharmaceutical litigation, overseeing strategy and execution in high-volume, high-stakes environments.
Alyson is ranked by Chambers USA for nationwide Product Liability & Mass Torts, where she is described as “a phenomenal case manager and a strong litigator.” She is also recognized by The Legal 500 US as a Next Generation Partner, noting her ability to manage both coordinated proceedings and individual cases while remaining attuned to business implications. Additional honors include Law360 Rising Star, Forbes® Best-In-State Lawyers (Class Action/Mass Tort), Lawdragon 500, Mid-South Super Lawyers, and Mississippi Business Journal’s Top 40 Under 40.
She earned her J.D., cum laude, from the University of Tennessee and her B.A., cum laude, from the University of Mississippi. Alyson is admitted to practice in Mississippi and Tennessee
-Emory University Institute for Complex Litigation and Mass Claims
-Next Generation Emerging Leaders, Board of Directors, 2017
-Rabiei Litigation Law Center Lawyers and Other Legal Experts Advisory Council
-American Bar Association
-Defense Research Institute (DRI)
-International Association of Defense Counsel (IADC)
-Capital Area Bar Association
-Hispanic National Bar Association
-Mississippi Bar Association
-Tennessee Bar Association
-Friends of Children's Hospital, Board of Directors, 2013-2019
-Century Club Charities, Board of Directors, 2015-2017
-UMMC Cancer Center Committee, 2024-Present
-Global Leadership Mentor Program, Jackson Preparatory School, 2015, 2023
-Ole Miss Women’s Council Mentor, 2023-Present
-Speaker, Discovery Issues Unique to Mass-Tort MDLs Bench-Bar Leadership Summit, Rabiei Litigation Law Center, Charleston, SC, March 13, 2025.
-Speaker, "Steering Committee Appointment Process," Advanced Strategy Mass-Tort MDL Certificate Course, GW Certificate Course, February 24, 2022.
-Speaker, Emory University Institute for Complex Litigation and Mass Claims Rising Stars Conference, Atlanta, GA, January 2018.
-Co-Author, “Physician Depositions: Who Goes First?," Pro Te: Solutio, Vol. 10 No. 3 (2017).
-Author, “Off-Label Promotion: Is It Free Speech?” Pro Te: Solutio, Vol. 7, No. 4, December 2014.
-Author, "Document Preservation Notices and the Lists of Who Receive Them: Are They Discoverable?," Pro Te: Solutio, Vol. 5, No 4 (November 2012).
-Author, "Update on Tort Reform Caps: Are They Constitutional?" Pro Te: Solutio, Vol. 3 No. 3, 6-7 (August 2010).
-Author, "Mississippi Tort Reform Faces Judicial Nullification Effort," Legal Opinion Letter, Washington Legal Foundation, February 12, 2010.
-Co-Author, "To Catch A Thief," Defense Research Institute, Drug and Device Seminar.
-Author, "Case Law: Sales Representatives, Diversity Jurisdiction and Fraudulent Joinder: Where do the Courts Stand," Pro Te: Solutio, Vol. 2 No. 3, 13 (July 2009).
-Author, "Limiting Adverse Verdicts: Tort Reform in Mississippi," Pro Te: Solutio, Vol. 1 No. 4, 2-5 (October 2008).
-Author, "Navigating Through the Serious Implications of an FDA Warning Letter," Pro Te: Solutio, Vol. 1 No. 2, 12-17 (April 2008).
-Speaker, Mississippi Dental Society Annual Meeting.
-Chambers USA: America’s Leading Lawyers for Business
-Product Liability & Mass Torts – Nationwide, 2025
-The Legal 500 U.S.
-Next Generation Partner, 2018-2025
-Lawdragon, 500 Leading Litigators in America, Pharmaceutical & Medical Device, Class Action, 2022, 2024-2025
-BL Rankings, The Best Lawyers in America®
-Product Liability Litigation – Defendants, 2018-2025
-Forbes®
-America’s Best-In-State Lawyers, Class Action/Mass Tort, Mississippi, 2025
-Law360
-Rising Star – Life Sciences, 2019
-2017 PORTICO 10
-Graduate, International Association of Defense Counsel (IADC) Trial Academy, Stanford Law School
-Thomson Reuters Super Lawyers®
-Mid-South Super Lawyers, Personal Injury – Products: Defense, 2013-2020
-Mid-South Rising Stars, Personal Injury – Products: Defense, 2010-2012
-Top 40 Under 40, Mississippi Business Journal, 2014
-Mississippi Bar Leadership Class, 2014
-Life Sciences Star, LMG Life Sciences
-Who's Who Legal
-Thought Leaders - USA - Life Sciences - Product Liability, 2023
-Life Sciences - Product Liability, 2020-2022
-Benchmark Litigation
-Future Star, 2025
MDL and Mass Tort Management
Coolsculpting® Litigation, (National Counsel), including Cates v. Zeltiq Aesthetics, Inc., Case No. 6:19-cv-1670-PGB-LRH, U.S.D.C. (M.D. Fla.) in which we obtained summary judgment, affirmed by the 11th Circuit, based on adequate labeling. “11th Circ. Freezes CoolSculpting User’s Product Liability Suit,” Law360, July 24, 2023
In re: Acetaminophen-ASD-ADHD Product Liability Litigation, MDL No. 3043, S.D.N.Y. (Key member of the defense team responsible for assisting with the defense of company witnesses)
In re: Propecia® (Finasteride) Product Liability Litigation, MDL No. 2331, E.D.N.Y. (Co-Lead Counsel).
In re: Propecia® Litigation, Case No. 623, Superior Court of New Jersey Law Division: Middlesex County (Co-Lead Counsel).
In re: Tylenol® (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436, E.D. Pa. (Defense Liaison Counsel).
Trial Team Support
Jackson v. McNeil-PPC, Inc., and Johnson & Johnson, Inc., No. ATL-L-880-13, Superior Court of New Jersey, Atlantic County: Tried in September 2015 involving Extra Strength Tylenol® - defense verdict; obtained summary judgment dismissing punitive damages.
Sessner v. Merck Sharp & Dohme Corp., Superior Court of New Jersey Law Division, Atlantic County: Second New Jersey bellwether product liability case involving prescription drug Fosamax®; defense verdict, 2012.
Maley v. Merck Sharpe & Dohme Corp., No. 1:06-cv-04110-JFK, S.D.N.Y., 2010: Second bellwether MDL trial in the Fosamax® litigation.
Boles v. Merck & Co., Inc., No. 1:06-cv-09455-JFK, USDC SDNY, 2009: First bellwether MDL trial in the Fosamax® litigation.
Brierton Johnson v. Johnson & Johnson, et al., No. TC 018540 - Los Angeles Superior Court in Malibu, 2008: California trial involving first product liability case in connection with Children’s Motrin® and Stevens-Johnson syndrome.
Kozic v. Merck & Co., Inc., No. 03-9248, Hillsborough County Circuit Court, Florida, 2007 (Vioxx® Litigation).
Cona v. Merck & Co., Inc., No. ATL-L-3553-05-MT -- Superior Court of New Jersey Law Division: Atlantic County, New Jersey, 2006 (Vioxx® Litigation).
McDarby v. Merck & Co., Inc., No. ATL-L-1296- 05-MT-- Superior Court of New Jersey Law Division: Atlantic County, New Jersey, 2006 (Vioxx® Litigation).
Albright v. Merck & Co., Inc., No. CV-05-02316 -- Jefferson County Circuit Court, Alabama, 2006 (Vioxx® Litigation).
Humeston v. Merck & Co., Inc., No. ATL-L-2272-03-MT -- Superior Court of New Jersey Law Division: Atlantic County, New Jersey, 2005 (Vioxx® Litigation).
Additional Experience
Client Secundment, January 2010 – 2013
Hunter v. Covin, et al., Forrest County – Second chair in three-day jury trial.
Provided by Chambers
Alyson Bustamante Jones serves as practice group leader for Butler Snow's pharmaceutical, medical device and healthcare group. She provides adroit representation to clients across these sectors in complex product liability disputes.
Provided by Chambers
Alyson is a phenomenal case manager and a strong litigator. She knows everything that is going on in all my cases at any given time, such that I can ask her any question and she knows the answer.
She is incredibly responsive. Alyson can jump in and is able to dig into the issues quickly. She also has a good understanding of what we need as a client.
Alyson is well prepared and extremely organized.
Alyson is a phenomenal case manager and a strong litigator. She knows everything that is going on in all my cases at any given time, such that I can ask her any question and she knows the answer.
She is incredibly responsive. Alyson can jump in and is able to dig into the issues quickly. She also has a good understanding of what we need as a client.
Alyson is well prepared and extremely organized.